Loading...

ATNM ACTINIUM PHARMACEUTICALS INC Management Changes 8-K Filing

CTNM

TNM

ACTINIUM PHARMACEUTICALS INC

(ATNM)

2026 8-K

Voting Frequency Update

Management Changes

Annual Meeting Results

Director Elections

Director Appointment

Regulatory Update

Election of Class I Directors

Regulation FD Disclosure

Phase 3 SIERRA trial results

External Links:

On February 11, 2026, Actinium Pharmaceuticals announced the resignation of CFO Steve O’Loughlin, effective February 27, 2026, with CEO Sandesh Seth appointed as his replacement. This transition is not due to any disagreements within the company.

AI Assistant

ACTINIUM PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.